An observational study in Wound, sponsored by BSN Medical GmbH. Completed at 3 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-07-20.
Sponsored by BSN Medical GmbH · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Documentation of the performance and safety of the debridement pad Cutimed DebriClean in daily clinical practice
60 subjects with superficial wounds in need of debridement will undergo mechanical debridement with the study product.
Per subject, one application of the study product will be documented including photo documentation of the wound and evaluation of the wound bed condition and wound size before and after the debridement.
2,221 studies on the registry are indexed under Wounds and Injuries; 442 are open to participants now.
This study's enrollment of 62 is below the median of 169 across 690 observational studies indexed under Wounds and Injuries.
Browse Wounds and Injuries studies →BSN Medical GmbH is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Subjects with superficial wounds in need of debridement, for example diabetic ulcers, venous and arterial ulcers, pressure sores, postoperative wounds and wounds healing by secondary intention, superficial burns, the absorption of exudate, slough and dry skin flakes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects will undergo one mechanical debridement procedure with Cutimed DebriClean
Device: mechanical debridement
The mechanical debridement is performed using the debridement pad Cutimed DebriClean. After the pad is moistened with wound-cleansing solution, the wound is cleaned using circular movements while applying gentle pressure.
Change of wound bed condition from baseline to assessment immediately after the mechanical debridement (within one study visit)
Percentage of wound coverage with debris/necrosis/slough Wound edge cleaned smooth Surrounding skin cleaned e.g. from skin flakes
Time frame: assessed immediately before and immediately after the mechanical debridement (within one study visit)
Wound size after and before wound debridement
Wound length and wound width are measured using a wound ruler. Wound size is calculated using the formula A = length x width x π/4.
Time frame: assessed immediately before and immediately after the mechanical debridement (within one study visit)
Time needed for the debridement procedure
Time from start to completion of the debridement procedure in minutes
Time frame: Time is measured during the debridement procedure
Debris/necrosis/slough absorbed by test product
assessed by the investigator (five categories)
Time frame: assessed immediately after the mechanical debridement
Structural integrity of the test product
assessed by the investigator (e.g. change in shape, loosening of fibers, ...)
Time frame: assessed immediately after the mechanical debridement
Pain during the debridement procedure
Patient reported pain assessed using a visual analogue scale. If applicable, duration of pain is documented.
Time frame: assessed immediately after the debridement procedure
Adverse device effects
Discomfort, pressure, burning sensation, bleeding, and irritation of the periwound skin during or after the mechanical debridement, other adverse device effects swelling; redness
Time frame: assessed immediately after the debridement procedure
Plan to share: No — No IPD will be shared. Data are needed for post market clinical follow up.
No publications or documents are linked to this record.
Ran from Apr 2021 to primary completion in May 2022, 13 months.
Of 47 industry-sponsored observational studies under Wounds and Injuries, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 63. This study's 13 months is below that.
Counting every sponsor, half of 312 studies reached it within 28 months; a quarter within 12 and three quarters within 60.
Wounds and Injuries covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
BSN Medical GmbH